Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Nov 14;136(20):1936-1938.
doi: 10.1161/CIRCULATIONAHA.117.031190.

Human Endogenous Retrovirus K and Pulmonary Arterial Hypertension: A New Take on a Retro Idea

Miranda K Culley  1 , Stephen Y Chan  2   3
Affiliations
Editorial

Human Endogenous Retrovirus K and Pulmonary Arterial Hypertension: A New Take on a Retro Idea

Miranda K Culley et al. Circulation. .
No abstract available

Keywords: Editorials; endogenous retrovirus; immune activation.

PubMed Disclaimer

Conflict of interest statement

M.K. Culley declares no conflicts of interest.

Figures

Figure.
Figure.. HERV-K may initiate or propagate the inflammation that defines pulmonary arterial hypertension.
Saito and colleagues propose a role for HERV-K in the pathogenesis of PAH. Specifically, HERV-K components induce SAMDH1 expression, resulting in cytokine release, endothelial apoptosis, and B-cell activation. How HERV-K is activated or its diagnostic and therapeutic implications are still undefined. HERV-K indicates human endogenous retrovirus K; IL, interleukin; PAH, pulmonary arterial hypertension; and TNF, tumor necrosis factor.
See this image and copyright information in PMC

Comment on

References

    1. Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014;115:165–175. doi: 10.1161/CIRCRESAHA.113.301141. - DOI - PMC - PubMed
    1. Degano B, Guillaume M, Savale L, Montani D, Jaïs X, Yaici A, Le Pavec J, Humbert M, Simonneau G, Sitbon O. HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era. AIDS. 2010;24:67–75. doi: 10.1097/QAD.0b013e328331c65e. - DOI - PubMed
    1. Cool CD, Rai PR, Yeager ME, Hernandez-Saavedra D, Serls AE, Bull TM, Geraci MW, Brown KK, Routes JM, Tuder RM, Voelkel NF. Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med. 2003;349:1113–1122. doi: 10.1056/NEJMoa035115. - DOI - PubMed
    1. Henke-Gendo C, Mengel M, Hoeper MM, Alkharsah K, Schulz TF. Absence of Kaposi’s sarcoma-associated herpesvirus in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2005;172:1581–1585. doi: 10.1164/rccm.200504-546OC. - DOI - PubMed
    1. Saito T, Miyagawa K, Chen S-Y, Tamosiuniene R, Wang L, Sharpe O, Samayoa E, Harada D, Moonen J- RAJ, Cao A, Chen P- I, Hennigs JK, Gu M, Li CG, Leib RD, Li D, Adams CM, del Rosario PA, Bill M, Haddad F, Montoya JG, Robinson WH, Fantl WJ, Nolan GP, Zamanian RT, Nicolls MR, Chiu CY, Ariza ME, Rabinovitch M. Upregulation of human endogenous retrovirus-K is linked to immunity and inflammation in pulmonary arterial hypertension. Circulation. 2017;136:1920–1935. doi: 10.1161/CIRCULATIONAHA.117.027589. - DOI - PMC - PubMed